Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Corona › NPI 1396842472
Lab

Pathology Arts INC

Pathology Arts INC was paid $5.72M by Medicaid between Jan 2018 and Nov 2024, across 9 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 79% of everything it billed.

33Billing provider infoPATHOLOGY ARTS INC
CORONA, CA 92879
33aNPI1396842472assigned 09/20/2006
28Total paid$5.72M
24GClaims82,342
24DCodes billed9
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in California

Rank by total paid#102 of 561
Median peer was paid$222K
This provider vs. median26×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$250K$500K$750K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018546$18K
2019259$3K
20203,380$233K
202142,405$3.06M
202223,855$1.65M
20237,112$509K
2024incomplete4,785$252K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 79% 60,127 54,137 $4.55M
88305 Level IV - Surgical pathology, gross and microscopic examination 9.2% 11,334 10,762 $524K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 7.8% 3,205 3,059 $445K
88342 1.1% 2,889 2,826 $63K
88341 <1% 523 506 $48K
88312 <1% 1,269 1,262 $43K
88304 <1% 1,285 1,264 $39K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 1,569 1,440 $9K
88313 <1% 141 137 $5K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialTAGUE, CURTIS (CEO)